Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Low numbers in the 10Q

Low numbers in the 10Q

posted on Apr 11, 2008 04:31PM

Maybe nobody else is getting the first mover discount and with the new agreements they pay low initial payment (barely enuf to cover court costs it seems) but pay royalties until the patents have expired.    This could explain why the 10Q looked so pathetic  (if you call millions "bad")

 

Share
New Message
Please login to post a reply